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Background/Aims: Unconjugated bilirubin (UCB) impairs crucial aspects of cell function and induces apoptosis in
primary cultured neurones. While mechanisms of cytotoxicity begin to unfold, mitochondria appear as potential
primary targets.
Methods: We used electron paramagnetic resonance spectroscopy analysis of isolated rat mitochondria to test the
hypothesis that UCB physically interacts with mitochondria to induce structural membrane perturbation, leading to
increased permeability, and subsequent release of apoptotic factors.
Results: Our data demonstrate profound changes on mitochondrial membrane properties during incubation with
UCB, including modified membrane lipid polarity and fluidity (P , 0:01), as well as disrupted protein mobility
(P , 0:001). Consistent with increased permeability, cytochrome c was released from the intermembrane space
(P , 0:01), perhaps uncoupling the respiratory chain and further increasing oxidative stress (P , 0:01). Both urso-
deoxycholate, a mitochondrial-membrane stabilising agent, and cyclosporine A, an inhibitor of the permeability tran-
sition, almost completely abrogated UCB-induced perturbation.
Conclusions: UCB directly interacts with mitochondria influencing membrane lipid and protein properties, redox
status, and cytochrome c content. Thus, apoptosis induced by UCB may be mediated, at least in part, by physical
perturbation of the mitochondrial membrane. These novel findings should ultimately prove useful to our evolving
understanding of UCB cytotoxicity.
q 2002 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Accumulation of unconjugated bilirubin (UCB) in the
central nervous system contributes to cell damage during
severe neonatal hyperbilirubinemia and Crigler-Najjar
type I syndrome leading to bilirubin encephalopathy [1,2].
In fact, numerous crucial aspects of cell function are
impaired by UCB [3–11], perhaps resulting in apoptotic
processes [11–13]. Though primary targets are still to be
identified, mitochondria have long ago been described as
particularly vulnerable to UCB-mediated toxicity [14–18].
To this end, we have recently demonstrated that exposure of
isolated mitochondria to UCB resulted in swelling and mito-
chondrial membrane permeabilisation [12]. Both cyclospor-
ine A, a known inhibitor of the megapore channel, and
ursodeoxycholate, which appears to exhibit an ubiquitous
protective effect involving the mitochondrial membrane
[19–21], prevented UCB-induced alterations. Finally, urso-
deoxycholate, also shown to protect from apoptosis by
modulating mitochondrial alterations, equally inhibited
UCB-induced toxicity in nerve cells [12,13]. Thus, mito-
chondria appear to mediate apoptosis by UCB, but the
underlying molecular mechanism(s) of toxicity remains
poorly understood.
Two major execution points in mammalian apoptotic cell
death involve caspase activation and mitochondrial
dysfunction [22,23]. Mitochondrial perturbation includes
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opening of the permeability transition pore, and is influ-
enced by multiple parameters, many of which induce apop-
tosis. These include collapse of mitochondrial
transmembrane potential, production of reactive oxygen
species, and release of cytochrome c from the intermem-
brane space, resulting in self-amplifying cascades. The
molecular mechanism(s) for release of caspase-activating
proteins from the mitochondria into the cytosol remains
controversial, but may involve direct interaction of the
apoptotic agent with the mitochondrial membrane.
In the present study, we used electron paramagnetic reso-
nance (EPR) spectroscopy analyses of isolated mitochon-
dria to test the hypothesis that UCB acts locally in
mitochondrial membranes to induce structural perturbation,
leading to the release of apoptotic factors. The results
demonstrate profound changes on mitochondrial membrane
properties during incubation with UCB, resulting in
disrupted membrane lipid polarity and order, as well as
modified protein mobility. As a consequence of altered
mitochondrial membrane permeability, cytochrome c is
released, perhaps inhibiting electron transfer in the respira-
tory chain and further increasing reactive oxygen species
production. Thus, apoptotic cell death induced by UCB
may be mediated, in part, by its effect of perturbing mito-
chondrial membranes.
2. Materials and methods
2.1. Mitochondria isolation
Low calcium brain and liver mitochondria were isolated from adult
Wistar rats as previously described [24–26]. Following isolation, mitochon-
dria were maintained on ice and used within 3 h of isolation. Protein
concentrations were determined using the Bio-Rad protein assay (Bio-
Rad Laboratories, Hercules, CA, USA). All animals received humane
care and the study protocol complied with the institution’s guidelines.
2.2. EPR spectroscopy and spin-labelling techniques
Changes in membrane structure can be measured by EPR spectroscopy
using paramagnetic reporter groups incorporated into membranes. The
polarity of mitochondrial membranes was examined at varying depths
with doxyl stearic acid spin labels (5-, 7-, and 16-DSA) (Sigma Chemical
Co., St. Louis, MO, USA), which contain a nitroxide group at different
positions along the hydrocarbon chain of the stearic acid molecule [27–
29]. In the 5-DSA probe, the paramagnetic centre resides near the lipid-
water interface, while in the 16-DSA localises deeper in the lipid bilayer. A
reliable parameter of the environment of these probes, calculated from
direct measurements of the parallel and perpendicular components of the
hyperfine tensor of the spin label, is the isotropic splitting factor a0. A high
a0 reflects increased polarity of the membrane. In addition, alterations in
membrane dynamic properties of 5- and 7-DSA probes, showing restricted
motion in the membrane, were evaluated by measuring the outer half-width
at half-height of the low-field extremum (Dl). The larger Dl, the more
motion and less order in the local microenvironment reported by the nitr-
oxide group. For the 16-DSA spin label, which showed a higher degree of
motional freedom, the ratio of the height of the low-field and the centre-
field line (h11/h0) was used as an empirical measurement of membrane lipid
organisation [30,31]. Finally, we tested the 4-maleimido-2,2,6,6-tetra-
methylpiperidinooxyl (4-maleimido-TEMPO) label (Sigma Chemical
Co.), which binds to the sulfhydril group of proteins giving information
about mobility of protein reactive groups and allowing measurement of
changes in structure of protein-rich membranes at the surface level
[29,32,33]. The ratio of the height of the midline to the height of the
high-field line of the spectrum (h0/h21) reflects the freedom of motion of
this probe at its binding site. A high ratio indicates a low freedom of motion.
All spin labels were dissolved in chloroform, separated into 1-mg
aliquots, evaporated under nitrogen, and left under vacuum for 2 h. Freshly
isolated intact mitochondria (100–150 mg protein) were incubated in spin-
label-coated tubes with gentle shaking, for 90 min at 378C, (5-, 7-, 16-
DSA), or for 1 min at 228C (4-maleimido-TEMPO), yielding systems
containing 5 mol spin label per 100 mol membrane lipids (5 mol.% probe).
Mitochondrial membrane lipid peroxidation was also assessed using EPR
as described previously [34–36]. In brief, freshly isolated mitochondria (5–
10 mg of protein) were incubated with two membrane-associated, oxida-
tion-sensitive, paramagnetic probes (1-mg aliquots), 5- and 12-DSA, with
gentle agitation for 20 min at 228C. Increased production of reactive oxygen
species results in loss of paramagnetism of the probe, and hence loss of
signal amplitude, measured as the height of the centre-field line of the
spectrum.
Labelled mitochondrial membranes were then exposed to UCB (0.9, 4.3,
and 8.6 mM) (Sigma Chemical Co.) in Chelex-100-treated respiration
buffer (10 mM HEPES, 10 mM succinate, 215 mM mannitol, 71 mM
sucrose, pH 7.4) for 5 min at 228C, yielding a molar ratio of approximately
2 mol UCB to 100 mol endogenous lipids. UCB concentrations were
selected based on the general believe that toxicity is cumulative and depen-
dent on concentration and exposure time. Thus, greater concentrations are
necessary to evaluate toxicity after short incubation periods required by the
instability of the molecule [37]. In co-incubation studies, labelled mito-
chondria were pre-treated with either ursodeoxycholate (500 mM) or
cyclosporine A (5 mM) (Sigma Chemical Co.) for 5 min, which remained
in the incubation medium. All studies used purified UCB [38] that was
dissolved in dimethylsulfoxide (0.86 mM stock solution), immediately
prior to use, and kept under light protection throughout the experiment.
Although never exceeding 1%, similar concentrations of dimethylsulfoxide
were added to relevant controls. After incubations, the mitochondrial
suspension was spun down at 12 000 £ g for 3 min, and the pellet resus-
pended in respiration buffer (60 ml). Samples were then sucked into glass
capillaries, sealed at both ends, and introduced in standard 4-mm quartz
tubes containing silicone oil for thermal stability. All spectra were acquired
at 9.8 GHz (X-band) on a Bruker EMX EPR spectrometer (Bruker, Karls-
ruhe, Germany) using a rectangular cavity (model ER 4102ST) and 100
kHz field modulation frequency, 1.05 G modulation amplitude and 20 mW
microwave power, at 228C.
2.3. Determination of cytochrome c content in supernatants
and mitochondrial pellets
Following incubations, mitochondria were centrifuged at 12 000 £ g for
3 min at 48C. Aliquots of supernatants and pellets were subjected to sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for detec-
tion of cytochrome c release. Proteins were separated on a 15% gel and
transferred onto nitrocellulose membranes. The immunoblots were treated
with 15% H2O2 for 15 min at room temperature and then sequentially
incubated with 5% milk blocking solution, primary monoclonal antibody
to cytochrome c (PharMingen, San Diego, CA, USA) at a dilution of 1:5000
overnight at 48C, and finally with secondary goat anti-mouse IgG antibody
conjugated with horseradish peroxidase for 3 h at room temperature.
Membranes were processed for cytochrome c detection using the enhanced
chemiluminescence light (ECL) reagent (Amersham Life Science, Inc.,
Arlington Heights, IL, USA).
2.4. Densitometry and statistical analysis
Densitometry was accomplished using a PC coupled to a PRIMAXe
9600 Profi VM6575 scanner (Primax International B.V., Utrecht, The Neth-
erlands). Quantitation of the autoradiograms used the ImageMaster 1D
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Elite densitometric analysis program (Amersham Pharmacia Biotech,
Uppsala, Sweden). Fold and percent changes both in EPR parameters and
protein levels were calculated based on corresponding controls. Differences
between groups were compared using the unpaired two-tailed Student’s t-
test, performed on the basis of equal or unequal variance as appropriate, and
P values lower than 0.05 were considered statistically significant.
3. Results
3.1. Increased lipid polarity and fluidity sensed by the 7-
DSA spin label reflect superficial interaction of UCB with
isolated mitochondrial membranes
To investigate the influence of UCB on mitochondrial
membrane polarity at varying depths, we used 5-, 7-, and
16-DSA spin labels. Interaction of UCB with mitochondria
resulted in decreased membrane polarity at a very superficial
level, indicated by the decline in a0 sensed by 5-DSA (Fig.
1A). In contrast, using the 7-DSA spin label, UCB caused a
marked, dose-dependent increase in membrane polarity,
which was more evident for lower UCB concentrations.
Deeper in the membrane leaflet, a0 was only slightly elevated
as revealed by the 16-DSA probe. Thus, UCB decreases
membrane polarity at the membrane-water interface, while
promoting increased permeability in more hydrophobic
regions. When a0 was expressed as percentage of control,
more pronounced alterations were detected at C-5 and C-7,
whereas only a slight increase in membrane polarity was
evident at C-16, greatly suggesting a superficial interaction
(Fig. 1B). Finally, UCB also increased membrane order in the
local microenvironment reported by 5-DSA. Using the 7-
DSA spin label, however, UCB markedly enhanced
membrane fluidity. Expressing the motion parameters Dl
and h11/h0 as percentage of control, a 5% increase in order
was evident at C-5, while 9 and 2% decreases were detected
at C-7 and C-16, respectively, corroborating the information
given by the parameter a0.
In contrast to the marked effects of UCB at C-7, urso-
deoxycholate and cyclosporine A alone marginally altered
the dynamic properties of mitochondrial membranes (Fig.
2A). However, both agents prevented UCB-induced altera-
tions. In fact, pre-treatment with ursodeoxycholate inhibited
the increase in mitochondrial membrane polarity caused by
UCB by almost 75% (P , 0:05), while cyclosporine A was
equally protective.
3.2. Disrupted protein order sensed by the 4-maleimido-
TEMPO spin label reflects mitochondrial membrane
instability induced by UCB
Using the protein-oriented spin label 4-maleimido-
TEMPO, the mobility parameter h0/h21 is definitely
decreased after exposure to 8.6 mM UCB (P , 0:001),
reflecting increased mobility of the probe and disrupted
order structure of mitochondrial membrane proteins at the
surface level (Fig. 2B). In contrast, ursodeoxycholate alone
markedly increased protein order (P , 0:001). Pre-treat-
ment with ursodeoxycholate completely abrogated UCB-
induced effects, increasing protein order above controls
(P , 0:001). These data suggests that stabilisation of the
mitochondrial membrane by ursodeoxycholate may explain
its ubiquitous protective role. Cyclosporine A alone did not
alter protein mobility compared with controls but inhibited
UCB-mediated perturbation (P , 0:05).
3.3. Cytochrome c release induced by UCB reflects
increased permeability in isolated mitochondrial
membranes
We then determined whether permeabilisation of the
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Fig. 1. UCB influences lipid polarity in rat mitochondrial membranes.
Mitochondria were labelled with either 5-, 7-, or 16-DSA spin probes
and then exposed to UCB in respiration buffer as described in Section
2. Mitochondrial pellets were examined for lipid polarity by EPR spec-
troscopy analysis. (A) Dose-response to UCB-induced alteration in
mitochondrial membrane isotropic hyperfine splitting constant (a0).
Labelled mitochondria were incubated with either UCB (0.9, 4.3, and
8.6 mM) or no addition (0 mM; control) for 5 min. (B) Percent change in
lipid polarity induced by 4.3 mM UCB through the depth of the mito-
chondrial membrane leaflet. Values are mean ^ SEM relative to
controls of at least three separate experiments. *P , 0:01 from control.
mitochondrial membrane by direct interaction with UCB
was accompanied by the release of intermembrane proteins,
such as cytochrome c. Levels of cytochrome c in superna-
tants of controls were undetectable and, likewise, addition
of either ursodeoxycholate or cyclosporine A did not signif-
icantly influence cytochrome c release. In contrast, mito-
chondria treated with UCB showed marked, dose-
dependent release of cytochrome c, while supernatant levels
were proportionally increased (Fig. 3, top). Pre-incubation
with either ursodeoxycholate or cyclosporine A prevented
efflux of cytochrome c by 30–60% (P , 0:05) (Fig. 3,
bottom). Thus, interaction of UCB with mitochondrial
membranes results in cytochrome c redistribution, which
appears to be mediated, at least in part, via the mitochon-
drial permeability transition pore opening.
3.4. Loss of spin-label intensity induced by UCB reflects
oxidative injury in isolated mitochondrial membranes
To determine if exposure to UCB modifies levels of mito-
chondrial membrane oxidation, isolated mitochondria were
probed with 5- and 12-DSA spin labels and then exposed to
UCB. UCB caused a rapid, dose-dependent loss of spin-
probe intensity, manifested by a decrease in peak amplitude
(Fig. 4A). Treatment with 0.9 mM UCB for 5 min did not
significantly alter 5-DSA signal amplitude, while 4.3 mM
concentrations caused a 14% decrease in spin-probe inten-
sity (P , 0:01). Decreases in signal amplitude were slightly
more marked at 15 min of incubation, but remained
unchanged for a subsequent 60-min incubation period
(data not shown). The magnitude of the 12-DSA signal
incorporated into mitochondria membranes was hardly
decreased during exposure to UCB, indicative of less
damage in deeper regions of the bilayer. Using a different
methodological approach to measure signal intensity, based
on the double integration of spectra, we confirmed the
results described above. In fact, 4.3 mM UCB led to an
almost 20% decrease of the 5-DSA signal amplitude as
compared to controls, while the 12-DSA signal was only
marginally affected.
Spin-label signal amplitude in isolated mitochondria was
also assessed in the presence of ursodeoxycholate (Fig. 4B).
Treatment of 5-DSA-labelled mitochondria with the bile
acid alone did not significantly decrease signal amplitude,
while incubation with ursodeoxycholate for 5 min prior to
exposure to 4.3 mM UCB markedly inhibited oxidative
injury. This protection resulted in signal amplitudes that
were no different from controls, indicating that ursodeoxy-
cholate either confers direct protection against lipid perox-
idation in isolated mitochondrial membranes or prevents
UCB insertion into the membrane indirectly inhibiting reac-
tive oxygen species production.
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Fig. 2. Ursodeoxycholate and cyclosporine A abrogate disruption of
lipid polarity and protein order induced by UCB in rat mitochondrial
membranes. Labelled mitochondria were exposed to either 4.3 mM
UCB, 500 mM ursodeoxycholate (UDC), 5 mM cyclosporine A (CsA),
UCB plus UDC, UCB plus CsA, or no addition (0 mM; control), for 5
min, in respiration buffer as described in Section 2. In co-incubation
experiments, mitochondria were pre-treated with either UDC or CsA
for 5 min. Mitochondrial pellets were examined for lipid polarity and
protein order by EPR spectroscopy analysis. (A) Alteration in mito-
chondrial membrane isotropic hyperfine splitting constant (a0) sensed
by the 7-DSA spin label. (B) Alteration in the ratio of the height of the
midline to the height of the high-field line (h0/h-1) sensed by the 4-
maleimido-TEMPO spin label. Values are mean ^ SEM relative to
controls of at least three separate experiments. †P , 0:05 from UCB
alone; *P , 0:01 from control; ‡P , 0:001 from control and UCB
alone.
Fig. 3. Dose-response of isolated mitochondria to UCB-induced cyto-
chrome c release and protection by ursodeoxycholate and cyclosporine
A. Mitochondria were incubated with either UCB (0.9, 4.3, and 8.6
mM), 4.3 mM UCB plus 500 mM ursodeoxycholate (UDC), 4.3 mM
UCB plus 5 mM cyclosporine A (CsA), or no addition (0 mM; control),
for 5 min, in respiration buffer as described in Section 2. Mitochondrial
pellets and supernatants were examined for cytochrome c levels by
Western blot analysis. Following SDS-PAGE and transfer, the nitro-
cellulose membranes were incubated with the monoclonal antibody to
cytochrome c and the 15-kDa protein was detected using ECL chemi-
luminescence. Blots are representative of at least three separate experi-
ments and the accompanying histograms are the densitometric
means ^ SEM relative to controls. *P , 0:01 from control.
4. Discussion
The present study demonstrates direct physical interac-
tion of UCB with isolated rat mitochondrial membranes,
wherein it acts to disrupt lipid polarity and fluidity, protein
order, and redox status. These novel findings, when taken
together with our prior studies showing morphologic char-
acteristics of apoptosis in cultured nerve cells exposed to
UCB [12,13], suggest that UCB-induced cytotoxicity may
be mediated, in part, by its effect of physically perturbing
the mitochondrial membrane structure.
The ‘physiologic jaundice’ of neonates is often an innoc-
uous condition, which conceivably represents a transitional
antioxidative mechanism in the neonatal circulation [39,40].
However, high concentrations of UCB can be neurotoxic
and, therefore, neonatal hyperbilirubinemia may exception-
ally result in death, or survival with severe neurological
sequelae [41]. Evidence indicates that UCB toxicity may
be a consequence of disrupted mitochondrial function
[12,14–18].
The present study suggests that UCB intercalates at C-5,
increasing phospholipid packing and thus reducing the
already low mobility of the phospholipid-acyl chain at this
region of the leaflet. Such a superficial effect renders inner
regions more permeable, as confirmed by the increased
polarity and fluidity at C-7 and C-16. Moreover, since
perturbation of the mitochondrial membrane induced by
UCB decreases from C-7 to C-16, it is conceivable that
this gradient results from a secondary effect to the super-
ficial accommodation of UCB. This scenario, although in
agreement with results obtained using an erythrocyte model
[42], does not exclude a possible interaction of UCB with
even more external regions of the leaflet. To this end, kinetic
and thermodynamic studies on the movement of UCB
between intracellular membranes have suggested that
UCB is associated with phospholipid bilayers at the
membrane-water interface [43]. Moreover, the solubility
characteristics of the molecule would not favour its inter-
calation between the phospholipid acyl chain [44]. The
increased permeability of the mitochondrial membrane
induced by UCB as described above is also supported by
the observation that UCB augments the mobility of the 4-
maleimido-TEMPO spin label, indicating disruption of the
protein order structure and increased membrane fluidity
much above control values. As a final note, UCB appears
to interact with mitochondrial membrane lipids in a fashion
similar to that described in a recent study using erythrocyte
membranes but, nevertheless, higher UCB concentrations
[42], thus suggesting a more generic perturbation.
In contrast to the effects of UCB, ursodeoxycholate
appears not to damage mitochondrial membranes but
when combined with the pigment almost completely inhi-
bits mitochondrial membrane instability. Further, using the
taurine conjugated derivative of ursodeoxycholate, a related
hydrophilic bile salt, we also detected significant protection
against UCB-induced perturbation (data not shown). The
stabilisation of the mitochondrial membrane by ursodeox-
ycholate reported in this study, and likewise suggested by
previously published data [19–21], provides an additional
explanation for its protective role at preventing apoptosis in
several model systems. Finally, we did not detect any major
disruption of lipid or protein surface structure induced by
cyclosporine A alone. This is in agreement with the matrix
location of cyclophilin D, the mitochondrial target of
cyclosporine A. However, cyclosporine A, abrogated the
effects of UCB on membrane structure. Thus, these results
although not excluding a direct physicochemical interaction
between UCB and cyclsoporine A, are consistent with a
protection that occurs via the inhibition of the permeability
transition pore.
The present study also demonstrates that cytochrome c is
released from isolated rat mitochondria following superfi-
cial insertion of UCB, and subsequent disruption of
membrane lipid polarity and protein order. Cytochrome c
redistribution is a common event in the cell death effector
pathway initiated by diverse apoptotic stimuli [45–47], even
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Fig. 4. Ursodeoxycholate prevents oxidative injury induced by UCB in
mitochondrial membranes. Mitochondria were labelled with either 5-
or 12-DSA spin probes and then exposed to UCB in respiration buffer
as described in Section 2. Mitochondrial pellets were examined for
reactive oxygen species production by EPR spectroscopy analysis. (A)
Dose-response to UCB-induced decrease in signal amplitude sensed by
5- and 12-DSA spin labels. Labelled mitochondria were incubated with
either UCB (0.9, 4.3, and 8.6 mM) or no addition (0 mM; control) for 5
min. (B) Alteration in EPR spectra sensed by the 5-DSA spin label.
Labelled mitochondria were exposed to either 4.3 mM UCB, 500 mM
ursodeoxycholate (UDC), UCB plus UDC, or no addition (control) for 5
min. In co-incubation experiments, mitochondria were pre-treated
with UDC for 5 min. Spectra are representative of at least three sepa-
rate experiments and values are mean ^ SEM relative to controls.
*P , 0:01 from control.
preceding exposure of phosphatidylserine and loss of
plasma-membrane integrity in apoptotic cells [48]. Never-
theless, the precise mechanism of cytochrome c efflux and
its regulation remain a matter of debate. Several reports
have provided evidence that redistribution occurs indepen-
dently of any detectable mitochondrial depolarization,
implying that opening of the megapore is a downstream
event to caspase activation [49]. However, data presented
here suggests that interaction of UCB with the mitochon-
drial membrane increases permeability, which in turn is
required for cytochrome c release. This is in agreement
with previous work, where mitochondrial permeabilisation
was shown to coincide with cytochrome c relocation, and
precede caspase activation [20,50,51]. Moreover, co-incu-
bation of mitochondria with ursodeoxycholate or cyclospor-
ine A resulted in significant inhibition of mitochondrial
permeability transition induced by UCB and, therefore,
prevented cytochrome c release.
Probably as a consequence of cytochrome c release, the
paramagnetism of both 5- and 12-DSA was decreased in
mitochondria incubated with UCB. Concentrations of
UCB in the low mM range induced membrane lipid perox-
idation by a mechanism that appears to involve direct inter-
action of UCB with the mitochondrial membrane with
subsequent release of cytochrome c, and then disruption
of the respiratory chain. Alternatively, reactive oxygen
species production may cause dissulfide formation in the
pore structure and open channels to release intermembrane
proteins. The release of cytochrome c may further inhibit
the transfer of electrons in the respiratory chain, again
increasing oxidative stress, in a vicious cycle.
In conclusion, our data indicate that the superficial inter-
action of UCB with the mitochondrial membrane likely
accounts for the disruption of lipid membrane polarity and
fluidity, and altered protein order induced by UCB. The
increased membrane permeability sensed by spin-label
EPR analysis is consistent with the reduced levels of cyto-
chrome c found in mitochondria, and can then lead to subse-
quent membrane lipid peroxidation. Thus, the results
suggest that UCB-induced cytotoxicity is mediated, at
least in part, by its effect of physically perturbing the mito-
chondrial membrane. These novel findings may ultimately
prove useful to our evolving understanding of UCB cyto-
toxicity.
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